Author: gradycampbell

Sunnyvale, CA – December 7, 2021 – Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana.

With the acquisition of RND, Gener8 is adding full lifecycle software development capabilities, including cloud solutions, verification & validation, quality system compliance, LIS/EHR integration and more. The company has assembled a library of protocols that serve to accelerate the development process by leveraging pre-built core functionality. While Gener8 already provides turnkey instrument and consumable solutions, as well as accompanying firmware, the acquisition of RND enables Gener8 to extend its services off-instrument to the related software.

“RND is a world-class medical software development operation with a blue-chip customer base and a unique set of capabilities,” said Jerry Jurkiewicz, Gener8 CEO. “We have already partnered on several programs, and the value proposition of the combination has strongly resonated with customers.”

“We are excited to join Jerry and the rest of the Gener8 team. From our early interactions it was clear there would be a great fit between our companies, and even more importantly, that bringing our capabilities together under one roof would be a real winner for customers,” added Tim DeFrench, Founder and President of RND.

About Gener8

Gener8, founded in 2002, is a leading provider of turnkey design and manufacturing services specializing in high complexity products, primarily for medical device and diagnostics applications. Gener8 maintains state-of-the-art facilities and a world-class engineering team with more than 40 PhDs spanning a multitude of disciplines, including electrical, mechanical, software, optical and systems engineering. For more information, please visit www.gener8.net. 

Irvine, CA – December 6, 2021 – Synoptek, leader in the global IT consulting field, today announced the strategic acquisition of Rapid Technologies, an Elite ServiceNow partner focused on consulting, implementation and managed services for ServiceNow’s industry-leading enterprise service management (ESM) solutions. The deal strengthens Synoptek’s ability to not only envision and implement ServiceNow solutions for its customers, but also to provide ongoing application support management offerings that will enable clients to get the most out of their investments.

Synoptek’s long and successful history of client partnerships within the ServiceNow ecosystem, paired with Rapid Technologies’ strong reputation for delivering ESM solutions, will reinforce Synoptek’s position as a leader in digital consulting, implementation and IT management. The relationship will also enhance business results through the two brands’ combined ServiceNow expertise.

“In today’s business climate, leaders are being extremely methodical when determining which computing strategies will push their organization to the next level, which has made ServiceNow a key platform to help support technology management,” said chief executive officer of Synoptek, Tim Britt. “As businesses form more and more reliance on their organizational technologies, they must demonstrate efficient operations and a sound return on the investment. ServiceNow is a critical tool for doing just that, and this acquisition gives us access to more expertise around a platform that has become so vital to our clientele. As we continue to build up our resources to support customer needs, acquiring Rapid Technologies was both a strategic decision and seamless fit.”

As a trusted ServiceNow partner, Rapid Technologies brings a level of expertise that Synoptek is poised to leverage and immediately incorporate into the company’s current service offerings. “This move truly allows Synoptek to further commit to a deeper global ServiceNow integration, while also utilizing Rapid Technologies’ like-minded focus on quality service and exceptional results,” added Britt.

Rapid Technologies has been delivering exemplary consulting and implementation services for successful ESM project deployment for over two decades. Providing superior expertise across industry verticals, the organization has seen ample growth as the demand for ServiceNow best practice guidance and ongoing support has increased. As part of the acquisition, Rapid Technologies chief executive officer and president, Bill Mell, along with current vice president of professional services, Charley Whitt, will serve as managing directors of the ServiceNow practice within Synoptek.

“The decision to merge with Synoptek provides extended service and solution offerings for our clients, as well as a major growth opportunity for both of our businesses,” said Mell. “As we leverage our combined team’s deep bench of expertise, we’re eager to continue our commitment to delivering innovative ServiceNow solutions to customers while making an impact in the communities that we serve.”

Along with its current IT leadership, consulting and managed service offerings, Synoptek will extend its ServiceNow arm with the addition of:

• Co-managed ServiceNow capabilities
• ServiceNow application managed services
• ServiceNow implementation and project expertise across the Now Platform®

“Above all, both parties are fully committed to accelerating client business outcomes through our collective value-added offerings. Our customers depend on flawless and persistent IT leadership and management of their systems, and the union of our industry-leading organizations will be key in executing that commitment,” concluded Britt.

About Synoptek

Synoptek is a business and technology consulting firm that helps companies envision, transform and evolve. As a global systems integrator and managed technology services provider, Synoptek partners with organizations worldwide to help them navigate the ever-changing technology landscape and build solid foundations for their business. With its comprehensive offerings, global workforce and strategic technology partnerships, Synoptek helps organizations grow their business while optimizing and protecting their ecosystem. With growth, ownership, inclusivity and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders. Discover more at www.synoptek.com, or connect with Synoptek on Facebook, Twitter and LinkedIn.

About Rapid Technologies

Rapid Technologies, an Elite ServiceNow partner, provides consulting, implementation and support services with a focus on giving back to the community through its ServiceNow for Good program.

Enters high-growth microfluidics and point-of-care diagnostics space

Nashua, NH – November 16, 2021 – Resonetics announced today that it has acquired Hudson Medical Innovations (Hudson), a leading manufacturer of microfluidics, point-of-care diagnostics (including application of reagents), biosensors, and advanced wound care devices, from Preco, Inc. Hudson was founded in 2012 and is based in Hudson, Wisconsin. The company’s responsive prototyping capabilities and proprietary, automated equipment has helped to establish a reputation as a supplier that supports customers with precise products from development to high-volume production.

“Hudson Medical Innovations is utilizing many of the same principles that have driven Resonetics’ growth:  a focus on the customer, innovative problem solving, and purpose-built equipment to scale production efficiently,” said Tom Burns, President and CEO of Resonetics. “The Hudson team has established a great position serving leading customers in very exciting high-growth markets, expanding the breadth and diversity of Resonetics.”

Hudson is Resonetics’ tenth acquisition in the past five years and continues to build upon the company’s leading position in advanced engineering and manufacturing solutions for the life sciences. Resonetics has over 1,600 employees that operate out of 13 sites located in key medical technology markets with facilities totaling more than 600,000 square feet.

About Resonetics

Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the life sciences industry. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, metal fabrication, and fiber optic sensors. With nine Lightspeed Application Development Labs located strategically to serve medical device companies around the world, Resonetics is built on a foundation of quality, speed, and innovation to deliver best-in-class value with a customer-centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, Israel, Switzerland, and Canada. Resonetics is owned by Regatta Medical, a portfolio company of GTCR. Learn more at www.resonetics.com.

About GTCR and Regatta Medical

Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Growth Business Services, Technology, Media & Telecommunications, Healthcare, and Financial Services & Technology Industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies. For more information, please visit www.gtcr.com. Regatta Medical was formed in April 2017 as a partnership between Robert “Chip” Hance, Mark Weishaar, and GTCR. Regatta Medical’s mission is to build a leading company in the medical device industry by acquiring outstanding medical device products and services businesses. For more information about Regatta Medical, please visit www.regattamedical.com.

Adds world-class fiber optic sensor solutions

Nashua, NH – November 9, 2021 – Resonetics announced today that it has acquired FISO Technologies Inc. (FISO), a leading developer and manufacturer of fiber optic sensors and signal conditioners, from Nova Metrix LLC. Founded in 1994, Quebec City-based FISO provides leading-edge fiber optic development capabilities and advanced manufacturing experience to support high-volume production of complex fiber optic products for the medical device and energy markets. FISO’s sensors provide reliable solutions for measuring parameters such as pressure, temperature, force, displacement, and position.

“We are excited to add FISO’s innovative fiber optic capabilities to provide our customers with improved access to another novel technology that’s already proven useful in several clinical applications” said Tom Burns, President and CEO of Resonetics. “FISO serves market leaders in interventional cardiology, critical care and women’s health and we believe the technology has broad application in other clinical areas”.

FISO sensors offer significant advantages over traditional solid-state technology:

• Extremely small size, flexible and kink resistant; highly suitable for minimally invasive disposable devices
• No electrical components (no interference with electrosurgical instruments and compatibility with MRI systems and RF-MW ablation devices)
• High frequency response and instantaneous readout to avoid signal attenuation and improve detection of transients
• Extremely accurate in situ measurements of any physiological event
• Robotic manufacturing for superior quality and high production volumes

FISO is Resonetics’ ninth acquisition in the past five years and continues to build upon the company’s leading position in advanced engineering and manufacturing solutions for the life sciences. Resonetics has over 1,500 employees that operate out of 12 sites located in key medical technology markets with facilities totaling more than 550,000 square feet.

About Resonetics

Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the life sciences industry. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel and precious metal tubing, photochemical machining, metal fabrication and fiber optic sensors. With nine Lightspeed Application Development Labs located strategically to serve medical device companies around the world, Resonetics is built on a foundation of quality, speed, and innovation to deliver best-in-class value with a customer centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, Israel, Switzerland, and Canada. Resonetics is owned by Regatta Medical, a portfolio company of GTCR. Learn more at www.resonetics.com.

About GTCR and Regatta Medical

Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Growth Business Services, Technology, Media & Telecommunications, Healthcare and Financial Services & Technology Industries. The Chicago-based firm pioneered The Leaders Strategy™ – finding and partnering with management leaders in core domains to identify, acquire and build market leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies. For more information, please visit www.gtcr.com. Regatta Medical was formed in April 2017 as a partnership between Robert “Chip” Hance, Mark Weishaar, and GTCR. Regatta Medical’s mission is to build a leading company in the medical device industry by acquiring outstanding medical device products and services businesses. For more information about Regatta Medical, please visit www.regattamedical.com.

Avon, CT – October 12, 2021 – First Fertility, a leading fertility company focused on patient experience, has launched its brand with plans to accelerate growth nationwide. Driving this effort is a group of industry experts from top fertility centers, specialty pharmacies, and pharmaceutical companies across the country, all joined together to expand access to care while providing unparalleled service for patients seeking fertility treatments and family-building options.

“We are building a network of best-in-class IVF centers with the singular purpose of putting our patients first,” commented Derek Larkin, CEO of First Fertility. “Each of our investments and innovations will be focused on continually improving the experiences of our patients. Our success is based entirely on the success of our patients, and we know that helping them reach their dreams of a family will make us First. We are changing the way that people experience fertility treatment and family building.”

With an ambitious expansion plan well underway, First Fertility has already established a prominent reputation across the United States through strategic partnerships with The Center for Advanced Reproductive Services, InVia Fertility, and RMA Long Island IVF, alongside recent acquisitions of Fertility Centers of New England and MCRM Fertility, with more to be announced soon.

Kim Rondeau, Chief Commercial Officer added, “This exciting new brand is the most visible part of a comprehensive strategic initiative to grow our reach throughout the country with new center partnerships that are focused on the highest quality of patient care. We meet our patients wherever they are in their journey toward parenthood while providing a level of expertise that is unmatched in our industry. Now, as we grow with these strategic partnerships and acquisitions, First Fertility will bring positive and transformative opportunity for fertility care in the United States.”

As First Fertility grows its diverse network of centers and reach under this new brand, its focus remains on delivering compassionate care that empowers patients to grow their family in the way they want.

Joseph Hill, M.D., President of Fertility Centers of New England said, “With an equal measure of compassion and skill, we have built Centers of Excellence that provide the highest level of fertility care that help people realize the dream of having a family. When you are a First Fertility patient, you are not just a number to us. You’re heard, you’re supported, and you’re an individual. You come first.”

About First Fertility

First Fertility offers comprehensive and customized care for patients to grow their families. The business partners with reproductive endocrinology practices across the United States, investing in and offering strategic opportunities to these Centers of Excellence so that physicians can focus on what matters most: taking care of their patients. Learn more at firstfertility.com.

Dallas, TX – September 16, 2021 – Cytracom, the leading provider of unified communications solutions delivered exclusively through managed service providers (MSPs), today announced the acquisition of OmniNet. OmniNet combines SD-WAN and cloud security to enable reliable, efficient, and secure connectivity without the need for or limitations of traditional, on-premises UTMs and firewalls.

“Cytracom is solely focused on enabling our partners to connect the modern workforce. Our mission began with building a partner-first voice platform that has since expanded to include rich integrations into the tools our customers are using every day, and most recently, a comprehensive business text messaging product which is changing the way businesses connect with their customers,” said Zane Conkle, Cytracom Co-founder and CEO. “The big challenge facing our partners today lies in secure and reliable connectivity, regardless of where employees are physically working. We are developing unique solutions to address this challenge, and the acquisition of OmniNet brings powerful technology to our product and engineering teams to accelerate this roadmap.”

OmniNet has developed a proprietary and patented methodology enabling businesses to extend the edge of corporate networks into the cloud. This technology, combined with best-in-class SD-WAN routing and prioritization, delivers a powerful and unique security and connectivity solution to the SMB market.

“Communication technologies depend on secure and reliable connectivity, and market demand for these solutions has exploded,” said John Tippett, Cytracom COO. “Our partners consistently report struggles with traditional solutions in the market today. OmniNet’s technology delivers the right combination of enterprise-grade connectivity and security — and Cytracom, with its proven track record of execution within the channel, is uniquely positioned to solve these challenges for the MSP community.”

Founded by and sold exclusively through MSPs, Cytracom products are fully designed and developed in-house; the company’s attention to user- and partner-centricity is a key differentiator in the UCaaS space. The OmniNet product, also built in-house, aligns with Cytracom’s commitment and capability to drive a product roadmap dedicated to partner success.

“Since its inception, OmniNet has helped MSP and IT service providers deliver simple but effective enterprise-grade security and connectivity solutions for their customers,” said Andrew Bagrin, OmniNet CEO. “Cytracom was the clear choice to continue this mission, remain committed to the channel, and help partners meet the ever-changing needs of the modern workforce.”

Neither OmniNet nor Cytracom users should expect immediate changes to service delivery or operations. However, partners should stay tuned for upcoming enhancements and new solutions.

About Cytracom

Cytracom, a Sverica Capital Management portfolio company, is Connecting the Modern Workforce by empowering small and medium-sized businesses (SMBs) with powerful yet intuitive cloud-based communication, connectivity and security solutions. Cytracom is exclusively available through its extensive network of managed service providers (MSPs) across the United States. The partner program offers tools and solutions that enable MSPs to efficiently deploy and manage the full product suite for their clients. This unique channel focus combined with a purpose-built and innovation-focused product line delivers an unparalleled solution in the market. To learn more visit cytracom.com.